|
Tell your friends to join our mailing list for updates on health news.
Don't forget to stop in and say HI!
HOT TOPICS
|  Apply for a CareCredit health care card. A no interest way to pay for health care over time. |
|
|
Join Our List
|
 |
|
|
|
| According to a bulletin put out by AETNA insurance company, there are many situations when HBOT is an approved treatment. Of course they have not approved many other situations for treatment to be covered by their insurance, but this is a step in the right direction.
Health insurance is a bit like car insurance. Car insurance only covers catastrophic problems like a car accident. It doesn't pay for tires, oil changes or wiper blades. Health insurance will help pay for acute care such as surgeries and a visit for strep throat, but often chronic problems which can be dealt with naturally are not covered.
Many people think that if their insurance won't cover something, then it's not necessary. Often if one would take steps on their own, outside of insurance, they could prevent the need for emergency care completely. Our focus at Kessinger Diagnostic Centre is to prevent illness and keep surgeries from being necessary, by helping individuals keep track of their health and make sure they are headed in the right direction.
Insurance companies need a name to put on an illness before they will consider it for payment. Because our focus is to prevent illnesses, many of the things we do are not covered by insurance. There is no insurance code for removing plaque from arteries, or preventing diabetes. It is up to each individual person to manage their own "oil changes" and make sure that they do not end up with an acute problem.
Below is the list that Aetna published 4-9-2010
Clinical Policy Bulletin: Hyperbaric Oxygen Therapy (HBOT)
Number: 0172
Policy
- Aetna considers systemic hyperbaric oxygen therapy (HBOT) medically necessary for any of the following conditions:
- Acute air or gas embolism
- Acute carbon monoxide poisoning
- Acute cerebral edema
- Acute peripheral arterial insufficiency (i.e., compartment syndrome)
- Acute
traumatic peripheral ischemia (including crush injuries and suturing of
severed limbs) when loss of function, limb, or life is threatened and
HBOT is used in combination with standard therapy
- Chronic refractory osteomyelitis, unresponsive to conventional medical and surgical management
- Compromised skin grafts and flaps
- Cyanide poisoning (with co-existing carbon monoxide poisoning)
- Decompression illness ("the bends")
- Exceptional
blood loss anemia only when there is overwhelming blood loss and
transfusion is impossible because there is no suitable blood available,
or religion does not permit transfusions
- Gas gangrene (Clostridial myositis and myonecrosis)
- Idiopathic sudden deafness, acoustic trauma or noise-induced hearing loss, when HBOT is initiated within 3 months after onset
- Non-healing
infected deep ulcerations (reaching tendons or bone) of the lower
extremity in diabetic adults unresponsive to at least 1 month of
meticulous wound care (including aggressive debridement, maximal
antibiotic therapy, tight glycemic control, and appropriate treatment of
arterial insufficiency, including revascularization if necessary). HBOT
is not considered medically necessary for superficial lesions.
- Pneumatosis cystoides intestinalis
- Progressive
necrotizing soft tissue infections, including mixed aerobic and
anaerobic infections (necrotizing fasciitis, Meleney's ulcer)
- Prophylactic pre- and post-treatment for members undergoing dental surgery of a radiated jaw
- Radiation necrosis (osteoradionecrosis, myoradionecrosis, brain radionecrosis, and other soft tissue radiation necrosis)
Radiation proctitis
- Aetna
considers the use of systemic HBOT experimental and investigational for
the following conditions (not an all inclusive list) because there is
insufficient evidence in the medical literature establishing that
systemic HBOT is more effective than conventional therapies:
- Actinic skin damage
- Actinomycosis and other mycoses
- Acute coronary syndrome
- Acute or chronic cerebrovascular insufficiency/accident (including thrombotic or embolic stroke)
- Acute renal arterial insufficiency
- Acute
thermal and chemical pulmonary damage, i.e., smoke inhalation (e.g.,
carbon tetrachloride, hydrogen sulfide) with pulmonary insufficiency
- Aerobic septicemia and systemic aerobic infection
- Anaerobic septicemia and infection other than clostridial
- Arthritic diseases
- Arthritis
- Aseptic necrosis of the femoral head and neck
- Autism
- Bell's palsy
- Bone grafts or fracture healing (e.g., nonunion fractures)
- Cancer
- Cardiogenic shock
- Cerebral palsy
- Chronic peripheral vascular insufficiency
- Closed head and/or spinal cord injury
- Cognitive impairment (e.g., senility, senile dementia)
- Crohn's disease
- Cystic acne
- Facial neuritis
- Frostbite
- Hepatic artery thrombosis
- Hepatic necrosis
- HIV infection
- Interstitial cystitis
- Intra-abdominal abscess, pseudomembranous colitis (antibiotic-induced colitis)
- Intracranial abscesses
- Ischemia due to lupus vasculitis
- Legg-Calve Perthes disease
- Lepromatous leprosy
- Lyme disease
- Melasma
- Meningitis
- Migraine or cluster headaches
- Multiple sclerosis
- Myocardial infarction
- Myofascial pain syndrome
- Necrotizing arachnidism
- Non-diabetic cutaneous, decubitus, pressure and venous stasis ulcers
- Non-vascular causes of chronic brain syndrome (e.g., Pick's disease, Alzheimer's disease, Korsakoff's disease)
- Ophthalmologic
diseases (including diabetic retinopathy, retinal detachment, central
retinal artery occlusion, central retinal vein occlusion, radiation
injury to the optic nerve, glaucoma, keratoendotheliosis)
- Organ transplantation and storage
- Osteoporosis
- Parkinson's disease
- Pulmonary emphysema
- Pyoderma gangrenosum
- Radiation-induced cystitis, myelitis, enteritis
- Reflex sympathetic dystrophy (complex regional pain syndrome)
- Sickle cell crisis or hematuria
- Skin burns (thermal)
- Superficial and/or non-infected diabetic ulcers
- Surgical wound dehiscence
- Tetanus
Tinnitus
- Aetna
considers systemic HBOT experimental and investigational for members
with any of the following contraindications to systemic HBOT, as the
safety of systemic HBOT for persons with these contraindications to HBOT
has not been established:
- Concurrent administration of doxorubicin, cisplatin, or disulfiram
- Premature infants (birth prior to 37 weeks gestation)
Untreated pneumothorax
- Aetna
considers topical HBOT administered to the open wound in small
limb-encasing devices experimental and investigational because its
efficacy has not been established through controlled clinical trials.
|
|
|
Sincerely,
Kessinger Health and Wellness Diagnostic Centre
Virginia, Amanda, Lucy, Liz, Krystal, Annette, Claudette, Tracy &
Jack Kessinger, DC, ND, DABCI
Jay Kessinger, DC, ND, DABCI, Registered DAN Doctor |
|
|